Ventyx Biosciences Ownership | Who Owns Ventyx Biosciences?


OverviewForecastFinancialsChart

Ventyx Biosciences Ownership Summary


Ventyx Biosciences is owned by 11.44% institutional investors, 4.13% insiders, and 84.43% retail investors. Blackrock is the largest institutional shareholder, holding 7.72% of VTYX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.43% of its assets in Ventyx Biosciences shares.

VTYX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVentyx Biosciences11.44%4.13%84.43%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock4.77M7.72%$11.02M
Blackrock funding, inc. /de4.50M6.37%$9.86M
Ubs group3.78M5.35%$8.28M
Vanguard group3.51M4.96%$7.68M
Tang capital management3.10M4.39%$6.79M
Sio capital management2.58M3.63%$2.97M
Vestal point capital, lp2.00M2.81%$2.30M
Point72 asset management1.78M2.52%$3.90M
Redmile group1.57M2.21%$1.81M
Goldman sachs group1.51M2.14%$3.31M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Qiming u.s. ventures management412.23K1.77%$902.77K
Sio capital management2.58M0.88%$2.97M
Tang capital management3.10M0.45%$6.79M
Sphera funds management1.01M0.40%$2.22M
Ikarian capital1.22M0.17%$1.40M
Redmile group1.57M0.17%$1.81M
Vestal point capital, lp2.00M0.16%$2.30M
Wexford capital lp398.46K0.14%$872.63K
Monaco asset management sam240.00K0.08%$525.60K
Tcg crossover management316.19K0.07%$692.47K

Top Buyers

HolderShares% AssetsChange
Ubs group3.78M0.00%2.59M
Point72 asset management1.78M0.01%1.78M
Redmile group1.57M0.17%1.45M
Blackrock4.77M0.00%1.02M
Jacobs levy equity management475.73K0.00%475.73K

Top Sellers

HolderShares% AssetsChange
Capital investors---5.25M
Farallon capital management---3.17M
Cormorant asset management, lp---2.71M
Octagon capital advisors lp---2.39M
Orbimed advisors---1.87M

New Positions

HolderShares% AssetsChangeValue
Point72 asset management1.78M0.01%1.78M$3.90M
Jacobs levy equity management475.73K0.00%475.73K$1.10M
Monaco asset management sam240.00K0.08%240.00K$525.60K
Susquehanna fundamental investments198.95K0.01%198.95K$435.69K
Bnp paribas arbitrage, snc126.14K0.00%126.14K$276.25K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-9.00
Zurcher kantonalbank (zurich cantonalbank)-55.00
Avion wealth-63.00
Federation des caisses desjardins du quebec-120.00
Modus advisors-150.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20259-92.91%8,136,748-85.06%110.19%4-94.20%3-89.66%
Dec 31, 20241211.68%53,151,2081.28%751.36%658.33%28-9.68%
Sep 30, 2024119-52,481,496-7.84%741.14%607.14%31-16.22%
Jun 30, 2024118-9.23%56,948,301-3.20%920.93%56-26.32%36-5.26%
Mar 31, 20241304.00%58,833,41036.04%991.85%76-3815.15%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A5.25M7.43%2.89M
Vanguard Total Stock Mkt Idx Inv1.78M2.50%-
iShares Russell 2000 ETF1.55M2.18%759.00
Vanguard Institutional Extnd Mkt Idx Tr873.00K1.23%-
Fidelity Small Cap Index619.86K0.87%-
iShares Russell 2000 Value ETF538.02K0.76%-
Delaware Healthcare I430.00K0.61%-
Macquarie Healthcare I430.00K0.60%-
State St Russell Sm/Mid Cp® Indx NL Cl C419.68K0.59%-
State St Russell Sm/Mid Cp® Indx SL Cl I419.68K0.59%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 02, 2025Nuss John CHIEF SCIENTIFIC OFFICERSell$2.02K
Dec 27, 2024Nuss John CHIEF SCIENTIFIC OFFICERSell$49.84K
Dec 23, 2024Gujrathi Sheila-Buy$300.57K
Dec 19, 2024Nuss John CHIEF SCIENTIFIC OFFICERSell$29.68K
Nov 25, 2024Mohan Raju CEO AND PRESIDENTBuy$524.94K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1--
2024 Q432
2024 Q3--
2024 Q2-4

VTYX Ownership FAQ


Who Owns Ventyx Biosciences?

Ventyx Biosciences shareholders are primarily institutional investors at 11.44%, followed by 4.13% insiders and 84.43% retail investors. The average institutional ownership in Ventyx Biosciences's industry, Biotech Stocks , is 63.96%, which Ventyx Biosciences falls below.

Who owns the most shares of Ventyx Biosciences?

Ventyx Biosciences’s largest shareholders are Blackrock (4.77M shares, 7.72%), Blackrock funding, inc. /de (4.5M shares, 6.37%), and Ubs group (3.78M shares, 5.35%). Together, they hold 19.44% of Ventyx Biosciences’s total shares outstanding.

Does Blackrock own Ventyx Biosciences?

Yes, BlackRock owns 7.72% of Ventyx Biosciences, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.02M$. In the last quarter, BlackRock increased its holdings by 1.02M shares, a 27.34% change.

Who is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested?

Qiming u.s. ventures management is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested, with 1.77% of its assets in 412.22K Ventyx Biosciences shares, valued at 902.77K$.

Who is the top mutual fund holder of Ventyx Biosciences shares?

American Funds SMALLCAP World A is the top mutual fund holder of Ventyx Biosciences shares, with 7.43% of its total shares outstanding invested in 5.25M Ventyx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools